Back
Intellia Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Sell
13
NTLA
Intellia Therapeutics
Last Price:
$6.86
Seasonality Move:
17.23%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.85 | Sell |
| 20-day SMA: | 8.47 | Sell |
| 50-day SMA: | 8.05 | Sell |
| 200-day SMA: | 13.54 | Sell |
| 8-day EMA: | 8.38 | Sell |
| 20-day EMA: | 8.46 | Sell |
| 50-day EMA: | 8.59 | Sell |
| 200-day EMA: | 13.28 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 38.33 | Sell |
| Chaikin Money Flow: | -7673207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.74 - 9.22) | Sell |
| Bollinger Bands (100): | (7.7 - 10.7) | Sell |
Intellia Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.87 while NTLA 8-day simple moving average is 8.85, which is a Sell signal.
-
The stock price of NTLA is 6.87 while Intellia Therapeutics 20-day SMA is 8.47, which makes it a Sell.
-
Intellia Therapeutics 50-day simple moving average is 8.05 while NTLA share price is 6.87, making it a Sell technically.
-
NTLA stock price is 6.87 and Intellia Therapeutics 200-day simple moving average is 13.54, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
13
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $6.87. The Score for NTLA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
711.6M
Price in USD:
6.87
Share Volume:
8.9M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
13
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 6.87 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 6.87 while NTLA 8-day exponential moving average is 8.38, which is a Sell signal.
-
The stock price of NTLA is 6.87 while Intellia Therapeutics 20-day EMA is 8.46, which makes it a Sell.
-
Intellia Therapeutics 50-day exponential moving average is 8.59 while NTLA share price is 6.87, making it a Sell technically.
-
NTLA stock price is 6.87 and Intellia Therapeutics 200-day simple moving average is 13.28, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.03 per share, and an increase next year of $0.29 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 38.33, which suggest Intellia Therapeutics is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics is (7.74 - 9.22), which suggest Intellia Therapeutics is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.7 - 10.7), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.